123
Views
13
CrossRef citations to date
0
Altmetric
CASE REPORTS

Mycobacterium Bovis Endophthalmitis from BCG Immunotherapy for Bladder Cancer

, &
Pages 95-97 | Received 28 Sep 2007, Accepted 11 Mar 2008, Published online: 08 Jul 2009

REFERENCES

  • Lamm D L. Efficacy and safety of bacille Calmette-Guerin immunotherapy in superficial bladder cancer. Clin Infect Dis 2000; 31(Suppl 3)S86–S90
  • Lamm D L, van der Meijden P M, Morales A, et al. Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol 1992; 147(3)596–600
  • Paterson D L, Patel A. Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: review of complications and their treatment. Aust N Z J Surg 1998; 68(5)340–344
  • Dehaven J I, Traynellis C, Riggs D R, Ting E, Lamm D L. Antibiotic and steroid therapy of massive systemic bacillus Calmette-Guerin toxicity. J Urol. 1992; 147(3)738–742
  • Damato F J. B. C. G. vaccine and phlyctenular kerato-conjunctivitis. Br J Ophthalmol. 1951; 35(7)416–418
  • Frandsen E. Eye lesions suspect of tuberculosis in BCG-vaccinated patients. Acta Ophthalmol (Copenh). 1953; 31(4)305–319
  • Wertheim M, Astbury N. Bilateral uveitis after intravesical BCG immunotherapy for bladder carcinoma. Br J Ophthalmol 2002; 86(6)706
  • Lester H, Erdey R A, Fastenberg D M, Schwartz P L, Rosenhaus J B. Bacillus Calmette-Guerin (BCG) endophthalmitis. Retina 1988; 8(3)182–184
  • Han D P, Simons K B, Tarkanian C N, Moretti S T. Endophthalmitis from Mycobacterium bovis-bacille Calmette-Guerin after intravesicular bacille Calmette-Guerin injections for bladder carcinoma. Am J Ophthalmol 1999; 128(5)648–650
  • Cambier J. Immunosenescence: a problem of lymphopoiesis, homeostasis, microenvironment, and signaling. Immunol Rev 2005; 205: 5–6
  • Vesosky B, Turner J. The influence of age on immunity to infection with Mycobacterium tuberculosis. Immunol Rev 2005; 205: 229–243
  • Moshfeghi D M, Dodds E M, Couto C A, et al. Diagnostic approaches to severe, atypical toxoplasmosis mimicking acute retinal necrosis. Ophthalmology 2004; 111(4)716–725
  • Dalessandro L, Bottaro E. Reactivation of CMV retinitis after treatment with subtenon corticosteroids for immune recovery uveitis in a patient with AIDS. Scand J Infect Dis. 2002; 34(10)780–782

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.